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Abstract
Background: Whiplash-associated disorder (or "whiplash") is a common condition incurring
considerable expense in social and economic terms. A lack of research on effective therapy for
patients with chronic whiplash associated disorders prompted the design of the current study. The
primary aim of this randomised controlled trial is to determine the effects of a physical activity
program for people with chronic (symptoms of > 3 months duration) whiplash. A secondary aim is
to determine if pain severity, level of disability and fear of movement/(re)injury predict response to
a physical activity program.
Methods / Design: This paper presents the rationale and design of a randomised controlled trial
examining the effects of advice and individualized sub-maximal exercise programs in the treatment
of whiplash associated disorders.
Discussion: This paper highlights the design, methods and operational aspects of a significant
clinical trial in the area of whiplash and chronic pain.
Background
Whiplash-associated disorder (WAD or "whiplash") is a
common condition incurring considerable expense in
social and economic terms. In Australia, the one year inci-
dence of whiplash is 106 per 100,000 [1]. As of June 1998,
whiplash was involved in 49,344 compulsory third party
claims in New South Wales (NSW) since 1995. The
incurred cost of these claims was $1466.3 M AUD [2].
Payments for loss of earnings for individuals who are tem-
porarily or permanently unable to return to usual work
activities are double the medical treatment costs and
account for 20% of claim costs [2].
Prognosis for whiplash is generally thought to be favour-
able. However, a recent systematic review by Cote et al
(2001) found that prognosis may vary according to the
population sampled and the compensation system of the
geographical area studied [3]. A large inception cohort
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study in Quebec showed that 22% of whiplash claimants
returned to their usual activities within 1 week, 53% by
one month, 70% by 3 months and 97% by one year post-
accident [4]. Importantly, a proportion of cases (30% in
Quebec) do not return to usual activities by 3 months.
These cases account for the majority of whiplash costs [5].
Therefore, treatments that effect an early return of subjects
to their usual activities, especially for those cases that fail
to recover by 3 months, ie chronic whiplash, have the
potential to significantly reduce social and economic
costs.
In a systematic review conducted in 2000, we located 86
randomised controlled trials evaluating therapy for neck
pain. Only 15 of the 86 trials identified directly looked at
whiplash. Of the 15 whiplash trials, only four studied
patients with chronic whiplash. Neither subcutaneous
water injections [6] nor intraarticular corticosteroid injec-
tions [7] were effective for chronic whiplash. The only
effective therapy is radiofrequency neurotomy [8], but the
technique is invasive, is delivered in a tertiary institution,
and is only indicated for subjects whose symptoms are
shown by diagnostic blocks to arise from the lower cervi-
cal zygapophyseal joints. In the majority (> 75%) of
claims involving whiplash, claimants report injuries to
other parts of the body [2]. Hence, for such patients, treat-
ment of the cervical spine joints in isolation is unlikely to
assist return to usual activities and therefore for many
patients with chronic whiplash, neurotomy may not be a
treatment option. This lack of research on effective ther-
apy for patients with chronic whiplash associated disor-
ders prompted the design of the current study.
There is evidence that two interventions assist patients
with sub-chronic (pain of 6 weeks to 3 months duration)
low back pain to return to their normal activities: 1) provi-
sion of education, reassurance and encouragement to
resume normal activity [9]; and 2) prescription of a phys-
ical activity program supervised by a therapist who guides
resumption of normal activities [10]. There is also evi-
dence that physical activity programs effectively return
patients with chronic low back pain to their normal activi-
ties [11]. This evidence for sub-chronic and chronic low
back pain has frequently led physiotherapists to manage
chronic pain from other sources with physical activity pro-
grams. Effective programs for low back pain are prescribed
from a detailed assessment of the patient and include
individualised, sub-maximal, progressively increased
exercises to train those functions found to be inadequate
for performance of work or leisure activities. Many pro-
grams incorporate principles of cognitive-behavioural
therapy, eg pacing and reinforcement in the exercise ses-
sions, and also address unhelpful beliefs such as fear of
pain or re-injury. Because many of the physical, psycho-
logical and social barriers to return to normal activity for
patients with chronic low back pain are also present in
patients with chronic whiplash, it is possible that a physi-
cal activity program will also benefit these patients.
Accordingly physical activity programs are increasingly
being used by physiotherapists to manage chronic whip-
lash although at present there is no direct evidence to sup-
port their use.
To date only one small trial [12](30 subjects) has evalu-
ated the use of physical activity in the management of
chronic whiplash. Chiropractic treatment and 'phasic'
exercise were found to reduce neck disability significantly
more than chiropractic treatment and 'standard' exercise.
However, neither form of exercise was clearly described
and the only outcome measured was disability immedi-
ately following treatment. It is therefore unknown
whether treatment effects were maintained, a critical issue
for chronic conditions.
We propose to evaluate the long term effects of a physical
activity program on the pain and disability associated
with chronic whiplash. Best practice will be evaluated,
using elements shown to be effective for chronic low back
pain (eg high intensity, supervision and principles of cog-
nitive-behavioural therapy) [11].
It is clear that the population with chronic whiplash is not
homogeneous, but includes patients with varying signs,
levels of pain and disability, attitudes and beliefs, who
experience widely divergent social and work environ-
ments [13]. It is therefore possible that sub-populations of
patients with chronic whiplash could be identified who
would respond differently to physical activity programs.
The prognostic factors for acute whiplash fall into three
categories: socio-demographic factors, crash-related fac-
tors and clinical findings [1], but there are no data on
prognostic factors for chronic whiplash, and no data on
predictors of response to treatment for chronic whiplash.
The proposed study will determine whether pain severity,
level of disability and fear of movement/(re)injury predict
treatment response in a chronic whiplash population.
This study has three primary aims:
1. The primary aim of this randomised controlled trial is
to determine the effects of a physical activity program for
people with chronic (symptoms of > 3 months duration)
whiplash.
2. A secondary aim is to determine if pain severity, level of
disability and fear of movement/(re)injury predict
response to a physical activity program.BMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/18
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3. A third aim is to evaluate the psychometric properties
of outcome measures that currently exist for the assess-
ment of chronic neck pain.
Methods
This randomized controlled trial will be conducted at two
treatment sites. Ethics approval has been gained from the
University of Sydney Human Ethics Committee.
Study population
One hundred and eighty subjects with chronic whiplash
will be recruited with the assistance of the Motor Acci-
dents Authority (MAA) of NSW. The MAA will provide the
researchers with a list of claimants who sustained a whip-
lash injury in a motor vehicle accident between three and
six months previously. In turn, the researchers will send
letters to claimants inviting them to participate in the
study. Claimants who volunteer to participate and satisfy
inclusion criteria will be randomly allocated to one of two
treatment groups: a group that receives advice; or a group
that receives a physical activity program in addition to
advice. No attempt is made to blind subjects or give equiv-
alent amounts of intervention to the two groups.
Verbal consent will be obtained over the phone in order
to establish whether or not the client is appropriate for the
trial. Written consent will be obtained at the initial assess-
ment prior to obtaining any further information from the
subject.
Inclusion Criteria
Volunteers will be screened by telephone and then at their
first clinic appointment. To be eligible for inclusion,
claimants must have presented for medical care of a whip-
lash associated disorder (WAD) grade I-III [3], (Table 1),
within one month of the accident (such cases will be iden-
tified by excluding WAD grades 0 and IV). Claimants must
also report that they are at least "mildly" disabled with
respect to pre-injury status. This will be achieved by asking
the question: "During the past week, how much has your
neck symptoms interfered with your normal (pre-injury)
activities (including work outside the home, housework,
sport, recreation and family activities)?" (Response
options: Not at all, Mildly, Moderately, Quite a bit, or
Extremely). At trial entry subjects must have significant
neck pain-related disability (indicated by a score of at least
20% on any one of the primary outcome measures,
obtained at the first clinic visit, see below).
Subjects will be allowed to participate regardless of
whether or not they are involved in litigation. Subject's lit-
igation status will be recorded at the initial assessment.
Exclusion Criteria
In the initial telephone interview a physical activity readi-
ness questionnaire will be used to screen for contraindica-
tions to exercise training. Subjects will also be excluded if
they have undergone neck surgery. Subjects will be
screened for "red flags". "Red flags" may indicate serious
pathology for which more appropriate medical interven-
tion is required. Where red flags are identified the person
will be referred for further investigation.
Volunteers not excluded by phone screening will be fur-
ther screened at the first clinic visit. Volunteers will be
excluded at this stage if they are classified as "severely" or
"extremely severely" depressed as measured by the
Depression Anxiety Stress Scale [14]. Subjects will also be
excluded if they exhibit clear neurological signs. A subject
will be deemed to have clear neurological signs if they
have two positive tests out of three (sensation, power and
reflexes) for the same spinal nerve root. All subjects will
require a cervical spine x-ray to participate. Subjects will
only undergo an x-ray investigation if films have not
already been taken since the accident. Subjects will be
excluded if X-rays reveal serious neck pathology such as an
undiagnosed fracture or dislocation.
Subjects will be excluded from the study if they are cur-
rently undergoing treatment for their whiplash condition.
Subjects will be asked to refrain from current treatment for
the duration of the trial and where possible, not change
current medications.
A letter will be sent to each subjects'medical practitioner
advising of the subject's participation in the trial. Results
of the screening process will also be given to general med-
ical practitioners.
A record will be kept of the number of invitations to par-
ticipate, the number of potential subjects who volunteer
to participate, and the number of screened patients who
are ineligible and the reason for their ineligibility. The
Table 1: Clinical Classification of Grades of WAD
GRADE CLASSIFICATION
0 No complaint about the neck. No physical sign(s).
I Neck complaint of pain, stiffness or tenderness only. No 
physical sign(s).
II Neck complaint AND musculoskeletal sign(s). 
Musculoskeletal signs include decreased range of motion 
and point tenderness.
III Neck complaint AND neurological sign(s). Neurological 
signs include decreased or absent tendon reflexes, 
weakness and sensory deficits.
IV Neck complaint AND fracture or dislocation.BMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/18
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researchers will only have access to the names and
addresses of claimants and not any other information
about potential subjects unless they are recruited into the
study. Ineligible patients and those who choose not to
participate will be referred for other care where
appropriate.
A list of information on symptoms will be obtained by
way of "red-flag" screening, questioning about contraindi-
cations to exercise testing and via a history taken by the
treating physiotherapist. This list will be used to describe
patients entering the trial and to determine whether
patients with other symptoms have different outcomes.
Baseline Measures
Immediately following the screening consultation, demo-
graphic data (age, gender, level of education) and employ-
ment status will be obtained via questionnaire. Two
measures of employment status will be obtained. A cate-
gorical measure of employment status (ie working full
time, full duties; or working full time, some duties; or
working part time, full duties; or working part time, some
duties; or employed but not currently working; or
employed but not currently working and undergoing re-
training; or unemployed, not working) and a continuous
measure of employment (ie, time since change in employ-
ment status). In addition, the following variables will be
measured:
• Average pain intensity over last 24 hours on a 0–10 scale
[15];
• Average bothersomeness of symptoms over last 24
hours on a 0–10 scale [16];
• A patient-specific measure of disability (Patient-Specific
Functional Scale) [17];
• A neck-specific measure of pain-related disability (Neck
Disability Index) [18];
• A generic measure of health status (SF-36) [19]; and
• Fear of movement/(re)injury (Tampa Scale for Kinesio-
phobia) [20];
These variables will be used to describe the study sample
and as baseline measures of outcomes.
Whiplash Associated Disorders incorporate a wide array
of symptoms and the number of primary outcome meas-
ures noted above will be used to cover the pain, disability
and quality of life changes experienced by such a popula-
tion. The scales chosen are simple to score, relevant to this
population and cover the aspects of WAD highlighted
above. The Neck Disability Index is the most established
of the scales and there is much known about the psycho-
metric properties. The pain scales we will use are used
widely and also have acceptable test properties. The SF36
is the most widely used generic health measure at present.
It is easy to administer and score and has Australian Nor-
mative data for the general population.
The psychometric properties of some of the outcome
measures that exist for chronic neck pain will be evaluated
as there has been limited evaluation of the test properties
of these measures. To investigate the responsiveness of
existing functional scales for neck pain, three further ques-
tionnaires will be issued to subjects: The Functional Rat-
ing Index [21], the Copenhagen Neck Functional
Disability Scale [22] and a modified Cumberland Whip-
lash Outcome Measure (CWOM) which is a scale devel-
oped specifically for this study based on the Proposed
Core Outcomes Measure of Deyo et al [23]. These scales
will be issued to each subject in order to compare the
responsiveness of these scales and the Neck Disability
Index to examine the internal consistency and factor struc-
ture of each measure to investigate the presence of floor
and ceiling effects and to determine which scoring meth-
ods are most appropriate for each scale.
Treatment allocation
Prior to the commencement of the study, a statistician not
otherwise involved in the study will generate the ran-
domisation schedule and produce a series of sealed, con-
secutively numbered, opaque envelopes, each containing
one subject's allocation. The statistician will retain a con-
fidential copy of the randomisation schedule so that the
accuracy of the randomisation process can be checked
after the trial is completed. Randomisation will be by ran-
dom permuted blocks of variable size from 6 to 10. Allo-
cation will occur immediately following the assessment
and advice session given by the treating physiotherapist.
This will ensure that the advice session is the same regard-
less of treatment group. At this time, the subject's name
will be written across the seal of the envelope and the
envelope's seal will then be broken. In this way conceal-
ment of allocation and blinding of baseline measures is
ensured. Subjects will be considered to have entered the
study at the time that the envelope is opened.
Treatments
After baseline measures have been collected, subjects will
be seen by the treating physiotherapist who will take a
complete history (including a symptom checklist), and
perform a physical examination. During this assessment,
current and pre-injury ability to perform work and home
activities will be established and measures of upper and
lower body mobility, coordination, strength and aerobic
fitness will be taken. On the basis of this assessment andBMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/18
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using the baseline measures, each subject will be given
advice (as below). Randomisation to treatment group will
occur after this advice has been given.
Subjects in the advice group will receive standardised edu-
cation, reassurance and encouragement to resume light
activity alone. The advice will be given in one consultation
and two follow-up phone contacts. The treating physio-
therapist will emphasise the favourable prognosis of
whiplash and address common inaccurate beliefs about
whiplash. Subjects will be told that physical activity, even
that which evokes moderate pain, is unlikely to further
damage the neck and back, and that excessive voluntary
limitation of activity may cause muscle weakness and
impede recovery. The physiotherapist will explore and
discuss the patient's understanding of whiplash and atti-
tudes and beliefs about activity resumption (eg fear of
increased pain or re-injury) that may impose barriers to
recovery. They will also be told that, because attempting
to return to normal activities as quickly as possible may be
the best possible therapy, no further treatment should be
necessary. Subjects will be given a written report covering
the main points of the advice session. Two and four weeks
later subjects will be contacted by telephone and the
standardised advice will be reinforced.
Subjects allocated to the physical activity program will
receive, in addition to the standardised advice described
above, an individualised physical activity program. The
six-week graded program will be carried out under super-
vision from a physiotherapist (3 sessions in the first and
second weeks; 2 sessions in the third and fourth weeks;
and 1 session in the fifth and sixth weeks). At the first exer-
cise session, baseline measures of upper and lower body
mobility, coordination, strength and aerobic fitness will
be established. From these assessments an individualised,
sub-maximal, progressive activity program will be devel-
oped to train those functions found to be inadequate for
performance of pre-injury work and home activities. At
the same time, the physiotherapist will guide the subject's
return to normal activities. Principles of cognitive-behav-
ioural therapy (CBT) will be used by the physiotherapists
in their training and supervisory roles [24]. Treating phys-
iotherapists will receive basic training in these skills from
a clinical psychologist (Author MN). The CBT principles
include the encouragement of skill acquisition by model-
ling, setting progressive goals, self-monitoring of progress,
and verbal positive reinforcement of progress. Self-reli-
ance will be fostered by encouraging subjects to engage in
problem-solving to deal with difficulties rather than seek-
ing reassurance and advice, by encouraging relevant and
realistic activity goals, and by encouraging self-reinforce-
ment. As noted above, the physiotherapist will explore
and discuss the patient's understanding of whiplash and
attitudes and beliefs about activity resumption (eg fear of
increased pain or re-injury) that may impose barriers to
recovery. Daily physical activity at home will be encour-
aged and monitored using a diary to enhance compliance.
Written and illustrated exercise instructions will be pro-
vided. Subjects may attend the gym at times other than
their scheduled appointments to complete exercises as
deemed appropriate by their therapist. Each subject will
receive 12 supervised sessions. A subject is able to cancel
up to 2 sessions without penalty, ie, these sessions will be
made up within the 6 week period. If a subject cancels or
fails to attend on more than 2 occasions, these sessions
will not be made up.
Subjects in both groups will be asked not to seek other
treatments and where possible not to change current med-
ications for the six-week trial period.
Several mechanisms will be used to ensure that the trial
protocol is consistently applied. Protocol manuals will be
developed and staff will be trained to ensure that screen-
ing, assessment, randomisation and treatment procedures
are conducted according to the protocol. Physiotherapy
interventions will be provided by independent physio-
therapists trained to administer the treatment protocols.
An independent researcher will monitor the conduct of
the study by reviewing a randomly chosen subset of
assessment, randomisation and treatment procedures.
If subjects are concerned about their condition during the
study, the physiotherapist will screen for potentially seri-
ous pathology and, where appropriate, refer to an adverse
effects committee who may refer on to a medical practi-
tioner. The medical practitioner will be asked not to seek
information on the subject's allocation unless it is
deemed necessary for medical care. After 6 weeks, inter-
ventions will cease, but both groups will be encouraged to
continue their attempts to return to normal activity. Sub-
jects will be free to seek other treatment after the experi-
mental period, although further treatment will not be
actively encouraged. Subjects will be requested to for-
mally record the type and amount of any treatments they
use.
Outcome measures
Measures of outcome will be obtained at the follow-up
appointments at 6 weeks (ie, at the end of the intervention
period) and at 12 months. Every attempt (within ethical
constraints) will be made to obtain outcome data, regard-
less of subjects' compliance with trial protocols. Follow-
up measures will be scored by a trial physiotherapist who
is unaware of group allocation. However, because treat-
ment outcomes are self-assessed by subjects, the trial can-
not be assessor-blinded.BMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/18
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The primary measures of clinical efficacy will be pain inten-
sity, bothersomeness of symptoms and subject-specific
disability at 6 weeks. Secondary measures of efficacy will be
the same measures at 12 months, as well as 6 week and 12
month measures of SF-36 physical and mental health
component summaries, the neck-specific measure of disa-
bility, and employment status. Functional Rating Index,
Copenhagen Neck Functional Disability Scale and Cum-
berland Whiplash Outcome Measures will be collected
from subjects as noted above so information on the
responsiveness of these measures can be gathered. Global
perceived effect will also be measured on a 10 point scale
(anchors at -5 indicating vastly worse, 0 indicating
unchanged, and 5 indicating completely recovered).
At both 6 weeks and 12 months, information about
adverse effects of treatment will be sought from all sub-
jects using open-ended questioning. In addition, subjects'
perceptions of the credibility of intervention will be
assessed at 6 weeks by questionnaire.
Compliance with the activity program will also be
assessed at 6 weeks by examining attendance records and
exercise diaries. Use of treatment (other than that pro-
vided as part of the trial) will also be assessed at 6 weeks
and 12 months by questionnaire. Subjects will be given
recommendations to formally record the amount and
type of treatment that they may receive.
Data analysis
Data will be coded to enable analysis by a "blinded" stat-
istician. The analysis will determine the size of the effect,
if any, of physical activity on primary and secondary out-
come variables. If physical activity is effective, further
analysis will determine whether pain severity, level of dis-
ability and fear of movement/(re)injury influence the
magnitude of the treatment response. Analysis will be by
intention-to-treat.
Separate analyses will be conducted to determine the
effect of treatment at 6 weeks and 12 months. The effects
of physical activity on each of the continuous outcome
measures will be analysed with multiple linear regression.
Baseline values of outcome measures will be used as cov-
ariates. The coefficient of the group membership variable
will provide an estimate of the effect of physical activity.
The dichotomous measure of employment status will be
analysed using survival analysis methods (Cox regression,
if the constant hazard assumption appears to be met, or
the log rank test) for time from randomisation until
return to work. This analysis will only include subjects
who reported at entry to the study that they were currently
not working because of whiplash-associated symptoms.
The hazard ratio will provide an estimate of the effect of
physical activity. Although the precision of this estimate is
likely to be low because of reduced sample size, employ-
ment status is sufficiently important to warrant inclusion
as a secondary outcome.
A conservative approach will be taken to analyse the pre-
dictive value of pain intensity, level of disability and fear
of movement/(re)injury on treatment responses. This
analysis will only proceed if at least one of the primary
analyses finds statistically significant effects of physical
activity (two-sided p < 0.05). In that case the three puta-
tive effect modifiers (pain intensity, level of disability and
fear of movement/(re)injury) will be added to the regres-
sion model one at a time, along with the term for interac-
tion with the treatment group.
The clinical and demographic data collected at baseline
will be inspected and if there are any clinically and impor-
tant differences in significant prognostic factors, these will
be used as covariates in any analysis performed.
Sample size
Sample size was determined using the procedures
described by Cohen [25]. We have assumed, probably
quite conservatively, a correlation between baseline meas-
ures and outcome scores of 0.4. A sample of 90 subjects
per group provides at least an 80% probability of detect-
ing an effect of exercise of 1.5 cm on the 10 cm VAS pain
intensity measure, 1.5 units on the 0–10 symptom both-
ersomeness scale and 10% on the 0–100% Neck Disabil-
ity Index. In our calculations, we assumed that the
standard deviation (SD) of pain intensity was 2.5 cm
(compare to 2.1 cm [17], 1.8 cm [8], 2.5 cm [7]) the SD
for symptom bothersomeness was 2.8 (compare to 2.8
[16]) and the SD for Neck Disability Index was 20% (com-
pare to 15% [26], 20% [27], 16% [17]), and that alpha
was 0.05. We allowed for 20% non-compliance with exer-
cise and 10% loss to follow-up (with losses to follow-up
equally distributed across compliant and non-compliant
subjects).
Responsiveness of Outcome Measures
As noted above, subjects will be issued with the Func-
tional Rating Index, the Copenhagen Neck Functional
Disability Scale and the Cumberland Whiplash Outcome
Measure. The responsiveness of these measures will be
compared with the Neck Disability Index. There does not
appear to be a consensus at present as to the best way to
evaluate responsiveness [28]. In this study, two
approaches will be used. Firstly we will calculate the effect
size and standardised response mean. Effect size is calcu-
lated by dividing the average change between initial and
follow up measures by the standard deviation of the ini-
tial measure [28]. The standardised response mean is cal-
culated by dividing the average change between initialBMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/18
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and follow up measures by the standard deviation of the
change score [28]. With these indices, the larger the score
the better the responsiveness. Secondly, the scores
obtained by each measure will be compared with the GPE
scale as an external measure of true change). Sensitivity
and Specificity will be calculated for a range of cut-offs for
improvement on the GPE scale and this information will
be used to plot an ROC curve for the measure. The area
under the ROC curve will be calculated. The area under
the curve can be interpreted as the probability of correctly
identifying a patient who has improved from randomly
selected pairs of patients who have and have not
improved. DeLong et al's [29] method of comparing ROC
curves will be used.
Further analyses will be undertaken to examine the inter-
nal consistency / factor structure of each scale to investi-
gate the presence of floor and ceiling effects of the
outcome measures [30].
Conclusions
We have presented the rationale and design of an RCT
examining the effects of advice and individualized sub-
maximal exercise programmes in the treatment of whip-
lash associated disorders. The primary aim of this ran-
domised controlled trial is to determine the effects of a
physical activity program for people with chronic (symp-
toms of > 3 months duration) whiplash. A secondary aim
is to determine if pain severity, level of disability and fear
of movement/(re)injury predict response to a physical
activity program. The results of this trial will be presented
as soon as they are available.
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